>> 全站文章索引 >> 第10页:
Neuropharmacology of 5-hydroxytryptamine - [A Richard Green1]
Focus on paroxetine. - [Green B]
MOOD, ANXIETY, AND PHYSICAL ILLNESS - [Balon R.]
Post-Stroke Depression in Primary Support Persons: Predicting Those at Risk - [Tompkins, Connie A.; Schulz, Richard; Rau, Marie T.]
Status of minor depression or dysthymia in primary care following a randomized controlled treatment - [Thomas E. Oxman, James E. Barrett, Anjana Sengupta, Wayne Katon, John W. Williams, Ellen Frank and Mark Hegel]
Steroid-Free Immunosuppression in Kidney Transplant Recipients and Prograf Monotherapy - [B?ckman L, Aselius H, Lindberger K, Svensson L, Str?mbom U, Olausson E, Hadimeri H, Deurell SI, Norrby J, G?bel M, Ebermark A, Olausson M.]
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. - [Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M]
A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial - [Linmarie Sikich1, Robert M Hamer1,2, Robert A Bashford1, Brian B Sheitman1,3 and Jeffrey A Lieberman1,4]
Detrimental Antidepressant Drug–Drug Interactions: Are They Clinically Relevant? - [Sheldon Preskorn1 and Steve Werder1]
Depressive personality disorder, dysthymia, and their relationship to perfectionism - [Huprich SK, Porcerelli J, Keaschuk R, Binienda J, Engle B.]
Depressive personality disorder, dysthymia, and their relationship to perfectionismsup?-sup - [Huprich SK, Porcerelli J, Keaschuk R, Binienda J, Engle B.]
Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts - [Lankupalle D Jayanthi, Gricelly Vargas, Louis J DeFelice]
Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography - [E. Lacassie, J. -M. Gaulier, P. Marquet, J. -F. Rabatel and G. Lachatre]
Vagus Nerve Stimulation (VNS?) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome - [Harold A Sackeim1,2,3 Ph.D, A John Rush5 MD, Mark S George7,8,10 MD, Lauren B Marangell11 MD, Mustafa M Husain5 MD, Ziad Nahas7 MD, Christopher R Johnson11 MD, Stuart Seidman1,2 MD, Cole Giller6 MD, Stephen Haines9 MD, Richard K Simpson Jr12 MD and Robert]
Mirtazapine Orally Disintegrating Tablet Versus Sertraline:A Prospective Onset of Action Study - [Behnke K, S?gaard J, Martin S, B?uml J, Ravindran AV, Agren H, Vester-Blokland ED.]
Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach - [H. Kirchherr and W.N. Kühn-Velten]
Training to recognise the early signs of recurrence in schizophrenia - [R Morriss, CA Bolton, MAMIR Faizal, M Marshall, JP McCarthy]
Mirtazapine versus other anti-depressive agents for depression - [N Watanabe, C Barbui, R Churchill, A Cipriani, TA Furukawa, McGuire HF and Omori I for the Meta-Analysis of New Generation Antidepressants (MANGA) Study Group]
The experience of bipolar disorder: a personal perspective on the impact of mood disorder symptoms - [J Licinio1]
Depression after cardiac transplant treated with interpersonal psychotherapy and paroxetine - [Mark Miller]
Posttraumatic stress disorder: A state-of-the-science review - [Charles B. Nemeroff, J. Douglas Bremner, Edna B. Foa, Helen S. Mayberg, Carol S. North and Murray B. Stein]
Paroxetine during lactation: is it really safe for the infant - [TW de Vries, LTW de Jong-van de Berg, M Hadders-Algra]
Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients - [Fouzia Laghrissi-Thode, Bruce G Pollock, Mark C Miller, Benoit H Mulsant, et al.]
Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior - [Deanna M Sasaki-Adams BS and Ann E Kelley Ph.D]
Evidence-based guidelines for the pharmacological treatment of anxiety disorders-recommendations from the British association for psychopharmacology - [Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU; British Association for Psychopharmacology.]
Antidepressants for the Treatment of Neuropathic Pain - [William E Cayley JR]
Interpersonal problems and emotional intelligence in compulsive hoarding - [Grisham JR, Steketee G, Frost RO.]
Affective disorders, antidepressant drugs and brain metabolism - [A Moretti, A Gorini and R F Villa]
Neurogenesis and depression-what animal models tell us about the link - [Vollmayr B, Mahlstedt MM, Henn FA.]
Effect of antidepressant drugs on 6-OHDA-treated mice in the FST - [F. Chenu, E. Dailly and M. Bourin]
Antidepressant Treatment and Dehydroepiandrosterone Sulfate: Different Effects of Amitriptyline and Paroxetine - [Michael Deuschle, Peter Luppa, Maria Gilles, Bettina Hamann, Isabella Heuser]
Sex differences in clinical response to olanzapine compared with haloperidol - [Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M, Crawford A, Tollefson G.]
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. - [Mogg K, Baldwin DS, Brodrick P, Bradley BP]
Alterations in platelet serotonin transporter binding in women with postpartum onset major depression - [D. Jeffrey Newport, Michael J. Owens, David L. Knight, Kim Ragan, Neal Morgan, Charles B. Nemeroff and Zachary N. Stowe]
Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene - [P Courtet1, P Baud2, M Abbar3, J P Boulenger4, D Castelnau1, D Mouthon2, A Malafosse2 and C Buresi2]
Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide - [B Bondy1, A Erfurth1, S de Jonge1, M Krüger1 and H Meyer2]
Bupropion (Zyban, sustained-release tablets): reported adverse reactions - [Hebert, Sylvie]
Major advances in bipolar disorder - [Mitchell PB, Malhi GS, Ball JR.]
Impaired platelet [(3)H]paroxetine binding in female patients with borderline personality disorder. - [Ng Ying Kin NM, Paris J, Schwartz G, Zweig-Frank H, Steiger H, Nair NP]
Diagnosis and management of depression in primary care: A clinical update and review - [Dr. R.A. Remick, Department of Psychiatry, St. Paul]
The effect of alexithymic features on response to antidepressant medication in patients with major depression - [Aytekin ?zsahin, M.D., ?zcan Uzun, M.D. *, Adnan Cansever, M.D., Zeynep Gulcat, Ph.D. AD:Department of Psychiatry, Gulhane School of Medicine, Ankara, Turkey]
Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring - [Christine Frahnert, Marie Luise Rao and Katja Grasm?der]
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain - [Agnès Besson, Nasser Haddjeri, Pierre Blier and Claude de Montigny]
Inclusion of the Antidepressant Paroxetine in β-cyclodextrin - [Mino R. Caira, Elise De Vries, Luigi R. Nassimbeni, Victor W. Jacewicz]
MONITORING THE SAFETY OF LICENSED MEDICINES - [Alasdair Breckenridge, Kent Woods & June Raine about the authors]
From Galactorrhea to Osteopenia: Rethinking Serotonin-Prolactin Interactions - [Ana B F Emiliano1,2 and Julie L Fudge1,3]
Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine - [J. Rodríguez Flores, J.J. Berzas Nevado, A.M. Contento Salcedo and M.P. Cabello Díaz]
Atypical antipsychotics in bipolar depression-Neurobiological basis and clinical implications - [Brugue E, Vieta E]
Paroxetine (Paxil, Seroxat): Increased risk of suicide in pediatric patients - [Eric Wooltorton]
FDA Advisory on Antidepressants - [Carrie Morantz, Brian Torrey]
PHARMACOKINETIC VARIABILITY OF ANTICANCER AGENTS - [Samir D. Undevia, Gonzalo Gomez-Abuin & Mark J. Ratain about the author]
Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive-Compulsive and Panic Disorders - [Pierre Blier MD, Ph.D and Claude de Montigny MD, Ph.D]
Social, Psychological, and Psychiatric Interventions Following Terrorist Attacks: Recommendations for Practice and Research - [Edna B Foa1, Shawn P Cahill1, Joseph A Boscarino2, Stevan E Hobfoll3,4, Mooli Lahad5,6, Richard J McNally7 and Zahava Solomon8]
Tail-suspension induced hyperthermia: a new measure of stress reactivity - [Xiaoqing Liu, Dorothy Peprah and Howard K. Gershenfeld]
An open trial of paroxetine for the offensive subtype of taijin kyofusho and social anxiety disorder - [Toshihiko Nagata, M.D., Ph.D. 1 *, Irene van Vliet, M.D. 2, Hisashi Yamada, M.D. 1, Kouhei Kataoka, M.D. 1, Toshiya Iketani, M.D., Ph.D. 1, Nobuo Kiriike, M.D., Ph.D. 1 1Department of Neuropsychiatry, Osaka City University Medical School, Osaka, Japan2Dep]
Application of the chiral base desymmetrisation of imides to the synthesis of the alkaloid jamtine and the antidepressant paroxetine - [Christopher D. Gill, Daniel A. Greenhalgh and Nigel S. Simpkins]
Overview of antidepressants currently used to treat anxiety disorder - [Feighner JP.]
Neurotransmitter transporters and their impact on the development of psychopharmacology - [Leslie Iversen1]
A call for the creation of personalized medicine databases - [David Gurwitz1, Jeantine E. Lunshof2 and Russ B. Altman3 About the authors]
Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats - [Andrew Harkin, Thomas J. Connor, Jane Mulrooney, John P. Kelly and Brian E. Leonard]
Cognitive Behavior Therapy and Paroxetine in the Treatment of Hypochondriasis: A Randomized Controlled Trial - [Anja Greeven, Anton J L M van Balkom, Sako Visser, Jille W Merkelbach, et al. The American Journal of Psychiatry. Washington:]
Genital sympathetic skin responses in fibromyalgia syndrome - [Unlü E, Ula? UH, Gür?ay E, Tuncay R, Berber S, Cak?i A, Odaba?i Z.]
Depression and its relation to lesion location after stroke - [MacHale, Siobhan M.; O, Rourke Suzanne; Wardlaw, Joanna M.; Dennis, Martin S.]
The spermicidal and antitrichomonas activities of SSRI antidepressants - [V.S. Kiran Kumar S.T., Vishnu Lal Sharma, Pratibha Tiwari, Divya Singh, Jagdamba Prasad Maikhuri, Gopal Gupta and Man Mohan Singh]
Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. - [Gilmor ML, Owens MJ, Nemeroff CB]
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product - [Scott P. Runyon, Jason P. Burgess, Philip Abraham, Kathryn I. Keverline-Frantz, Judy Flippen-Anderson, Jeffrey Deschamps, Anita H. Lewin, Hernán A. Navarro, John W. Boja, Michael J. Kuhar, et al.]
Validation of a Depression Screening Measure for Stroke Inpatients - [Rybarczyk, Bruce Ph; Winemiller, David R.; Lazarus, Lawrence W.; Haut, Allyson Ph; Hartman, Carolyn M.]
Depressing research - [Anonymous]
Immunomodulators as an antimicrobial tool - [Pirofski LA, Casadevall A.]
A novel serotonin transporter ligand: (5-Iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol - [Zhi-Ping Zhuang, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton and Hank F. Kung]
High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions - [Per Plenge and Ove Wiborg]
Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders - [Y W-Y Yu1, S-J Tsai2,3, T-J Chen4, C-H Lin4 and C-J Hong2,3]
Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain - [Pilar Rosel 1, Belén Arranz 2, Miguel Oros 1, Julio Vallejo 3, Luis San 2, Jan Marcusson 4, Miguel A. Navarro 1 AD:1Hormone Unit, Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain2Benito Menni, Mental Health Care Institute, Barcelona, Spain]
PLATELET SEROTONERGIC BINDING SITES IN ALCOHOL-DEPENDENT PATIENTS - [Belen Arranz, Pilar Rosel, Salvador Sarro, Encarna Zaldivar, Ramon Cano, Miguel Angel Navarro, Luis San]
Serotonin Receptor and Transporter Ligands - Current Status - [S. Oh, H-J. Ha, D. Chi, H. Lee]
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice - [F.O. Goeldner, G. Pigatto, A.F. Ribeiro, H.B. Machado and R. Boerngen-Lacerda]
Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder - [D. Joel, J. Doljansky, N. Roz and M. Rehavi]
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers - [Liston HL, DeVane CL, Boulton DW, Risch SC, Markowitz JS, Goldman J.]
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review - [Meera Vaswani, Farzana Kadar Linda and Subramanyam Ramesh]
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. - [Nic Dhonnchadha BA, Ripoll N, Clenet F, Hascoet M, Bourin M]
R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study - [Susanne Koch Ph.D, Kenneth W Perry MS, David L Nelson Ph.D, Richard G Conway MS, Penny G Threlkeld MS and Frank P Bymaster MS]
Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder - [Frank P Bymaster MS, Jason S Katner BS, David L Nelson Ph.D, Susan K Hemrick-Luecke MS, Penny G Threlkeld MS, John H Heiligenstein]
AntidepressantA–Drug Interactions are Potentially but Rarely Clinically Significant - [DeVane CL.]
Antidepressant–Drug Interactions are Potentially but Rarely Clinically Significant - [C Lindsay DeVane1]
Drug Safety Monitoring of 12692 Patients Treated with Fluoxetine - [J. GUY EDWARDS 1, WILLIAM H. W. INMAN 2, LYNDA WILTON 3, GILLIAN L. PEARCE 3, KIYOSHI KUBOTA 4 AD:1University of Southampton, Faculty of Medicine, Health and Biological Sciences, Department of Psychiatry, Royal South Hants Hospital, Southampton SO14 0YG,]
Glutamatergic Dysfunction in OCD - [Kaushik Chakrabarty1, Sagnik Bhattacharyya2,5, Rita Christopher3 and Sumant Khanna4,5]
Is there evidence for negative effects of antidepressants on suicidality in depressive patients A systematic review - [M?ller HJ.]
An Interaction Between Aspirin and Valproate: The Relevance of Plasma Protein Displacement Drug-Drug Interactions - [Neil B Sandson, Catherine Marcucci, Denis L Bourke, Rosemary Smith-Lamacchia. The American Journal of Psychiatry. Washington:]
Paroxetine (Paxil) and congenital malformations - [Megan Williams, Eric Wooltorton]
Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression - [Bruce G Pollock1 MD, Ph.D, Robert E Ferrell3 Ph.D, Benoit H Mulsant1 MD, Sati Mazumdar4 Ph.D, Mark Miller2 MD, Robert A Sweet1 MD, Stephanie Davis1 MEd, Margaret A Kirshner1 BA, Patricia R Houck2 MS, Jacqueline A Stack2 MSN, Charles F Reynolds III2 MD and]
Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine - [C. Charlier 1 *, E. Pinto 2, M. Ansseau 2, G. Plomteux 1 AD:1University of Liège, Toxicology Laboratory, CHU Sart Tilman, B-4000 Liège, Belgium2University of Liège, Psychiatric Unit, CHU Sart Tilman, B-4000 Liège, Belgium]
Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM - [Supported by the National Alliance for Research in Schizophrenia and Depression (NARSAD), the Lieber Center for Schizophrenia Research at Columbia University and the Public Health Service (NIMH K02 MH01603–0, NIMH MH59342–01, NIAAA IP50 AA-1287001).]
Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria - [J. Melke, L. Westberg, M. Landén, C. Sundblad, O. Eriksson, F. Baghei, R. Rosmond, E. Eriksson and A. Ekman]
Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test - [Thomas J. Connor, Padraig Kelliher, Yan Shen, Andrew Harkin, John P. Kelly and Brian E. Leonard]
Plasma Anti-Serotonin and Serotonin Anti-Idiotypic Antibodies Are Elevated in Panic Disorder - [Jeremy D Coplan MD, Hadassah Tamir Ph.D, Denise Calaprice Ph.D, MaryBeth DeJesus BA, Manuel De La Nuez BA, Daniel Pine MD, Laszlo A Papp MD, Donald F Klein MD and Jack M Gorman MD]
Prolactin Response to dl-Fenfluramine Challenge before and after Treatment with Paroxetine - [Michael C Dulchin MD, Maria A Oquendo MD, Kevin M Malone MD, Steven P Ellis Ph.D, Shuhua Li Ph.D and J John Mann MD]
Angiogenesis in malignant glioma—A target for antitumor therapy - [Tuettenberg J, Friedel C, Vajkoczy P.]
Sexual function during bupropion or paroxetine treatment of major depressive disorder. - [Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S]
Treatment of depression and concomitant anxiety - [David Nutt]
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain - [Kazufumi Hirano, Syuji Maruyama, Ryohei Kimura, Yoshiyuki Kagawa and Shizuo Yamada]
分页: 1 2 3 4 5 6 7 8 9 [10] 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |